This video examines clinical and genomics data from the NCI 9012 trial, which studied abiraterone combined with a PARP inhibitor in patients with metastatic castration-resistant prostate cancer. (Source: CancerNetwork)
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tdYzkt
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Purpose: The MHC-unrestricted activity of cytokine-induced killer (CIK) cells against chemo-surviving melanoma cancer stem cells (mCSC) was...
-
9780275967376 0275967379 Realism and American Foreign Policy - Wilsonians and the Kennan-Morgenthau Thesis, Steven J. Bucklin Vin Diesel, Pa...
-
We first prove Mazur’s lemma in a random locally convex module endowed with the locally -convex topology. Then, we establish the embedding t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου